Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
04/08/2026
The Indian BSE Sensitive Index has widened its decline, falling by 0.5% recently.
Latest
1 m ago
Longqi Technology (09611.HK) spent 8.7231 million yuan on August 4 to repurchase 243,300 A-shares.
1 m ago
Jingsong Intelligence: Plans to repurchase company shares for 15 million to 20 million yuan.
1 m ago
Jiangsu Bank: Net profit in the first half of 2026 was 21.876 billion yuan, a year-on-year increase of 8.09%.
2 m ago
Haixi New Drugs (02637): HX9428 for the treatment of neovascular age-related macular degeneration has received IND approval from the US FDA to initiate Phase II clinical trials, while a second Phase II clinical trial with a positive control has been launched in China.
2 m ago
Laiersdan (00738.HK) spent HKD 115,000 on August 4 to buy back 400,000 shares.
See all latest